Connection

Richard Drake to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Richard Drake has written about Antibodies, Monoclonal, Humanized.
Richard Drake
Connection Strength
0.027
Antibodies, Monoclonal, Humanized
  1. A phase II trial of paclitaxel, carboplatin, and bevacizumab in advanced and recurrent endometrial carcinoma (EMCA). Gynecol Oncol. 2015 Feb; 136(2):240-5.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.